from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3597c/lsr2

LFCtreatmentdescriptionclass of inhibitor

3.303

Amikacinug/mL Amikacintranslation

1.787

Cap5-10ug/mL Capreomycintranslation

1.904

Rox10-50 ug/mL Roxithromycintranslation

0.908

SM2-5 ug/mL Streptomycintranslation

3.029

Tet5-10 ug/mL Tetracyclinetranslation

-0.963

Rif0.2-5ug/mL Rifampicintranscription

-1.178

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.525

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.515

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.324

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.485

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.507

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.022

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.766

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.246

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.544

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.027

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.776

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.333

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.041

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.233

KCN5-20 ug/mL Potassium cyaniderespiration

-0.202

NaN30.2-2 mM Sodium aziderespiration

1.764

Nigericin50 uM Nigericinrespiration

0.214

TRC10-150 ug/mL Triclosanrespiration

0.751

TRZ10-25 ug/mL Thioridazinerespiration

1.394

Valinomycin0.5-10 uM Valinomycinrespiration

-0.108

ZnSO42 mM ZnSO4respiration

-0.765

menadione6-10 ug/mL Menadionerespiration

-0.572

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.234

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.197

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.087

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.671

NRP_1Non-replicating persistence stage 1dosRassociated

0.166

Amp0.2mg/mL AmpicillincellWall

0.223

Cephalexin20-100 ug/mL CephalexincellWall

0.190

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.471

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.303

EMB10-20 ug/mL EthambutolcellWall

0.664

Eta12-40 ug/mL EthionamidecellWall

1.537

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.499

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.359

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.146

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.338

BZA0.12 mg/mL BenzamidearomaticAmides

0.676

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.249

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.560

H2O24 mM hydrogen peroxideDNAdamaging

-0.412

Levo10 ug/mL LevofloxacinDNAdamaging

-0.231

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.176

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.436

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.155

UVUV-irradiationDNAdamaging

-1.442

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.405

Antimycin12.5-50 ug/mL Antimycin A?

0.101

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.246

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.119

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.392

PA8240.2-2 ug/mL PA-824?

-0.444

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.033

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.129

Verapamil50 uM Verapamil?

-0.023

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.545

methoxatin10-20 ug/mL Methoxatin?